NCT00529490 - Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats | Biotech Hunter

Enrollment

230

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

June 30, 2003

Conditions

Low Cardiac Output

Interventions

DRUG

Hypertonic lactate

Parenteral solution administered to a maximal volume of 10 ml/kg BW over the first 12 hours post-CABG

DRUG

Ringer's lactate

Parenteral solution administered to a maximal dose of 30 ml/kg BW over the first 12 hours post-CABG

Trial Locations (1)

National Cardiac Center, Department of Surgery and Intensive Care Unit, Harapan Kita Hospital, Jakarta